| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 3.69e-05 | 103 | 120 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | peptidase activity | MASP1 RELN TMPRSS15 CAPN3 CPA2 SENP8 F12 USP19 DPP9 CPNE1 MINDY4 MMP8 AGBL2 ENPEP | 3.88e-05 | 654 | 120 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | calcium ion binding | TRPM4 MASP1 CALU CAPN3 KCNIP3 KCNIP1 F12 ITIH1 CEMIP2 THBS4 FAT2 MEGF8 CPNE1 GCA MMP8 | 4.34e-05 | 749 | 120 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | ethanolamine kinase activity | 2.13e-04 | 4 | 120 | 2 | GO:0004305 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.36e-04 | 144 | 120 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | galactosylceramidase activity | 3.54e-04 | 5 | 120 | 2 | GO:0004336 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 6.90e-04 | 29 | 120 | 3 | GO:0005540 | |
| Domain | EF-hand_8 | 2.41e-06 | 34 | 120 | 5 | PF13833 | |
| Domain | CUB | 1.53e-05 | 49 | 120 | 5 | PF00431 | |
| Domain | CUB | 1.69e-05 | 50 | 120 | 5 | SM00042 | |
| Domain | - | 2.06e-05 | 52 | 120 | 5 | 2.60.120.290 | |
| Domain | CUB | 2.26e-05 | 53 | 120 | 5 | PS01180 | |
| Domain | CUB_dom | 3.23e-05 | 57 | 120 | 5 | IPR000859 | |
| Domain | POLO_box_2 | 1.22e-04 | 3 | 120 | 2 | IPR033695 | |
| Domain | DP | 1.22e-04 | 3 | 120 | 2 | PF08781 | |
| Domain | Transcrpt_fac_DP | 1.22e-04 | 3 | 120 | 2 | IPR015648 | |
| Domain | Transc_factor_DP_C | 1.22e-04 | 3 | 120 | 2 | IPR014889 | |
| Domain | DP | 1.22e-04 | 3 | 120 | 2 | SM01138 | |
| Domain | - | 2.44e-04 | 4 | 120 | 2 | 3.30.1120.30 | |
| Domain | G8_domain | 2.44e-04 | 4 | 120 | 2 | IPR019316 | |
| Domain | POLO_box | 2.44e-04 | 4 | 120 | 2 | PF00659 | |
| Domain | POLO_box_1 | 2.44e-04 | 4 | 120 | 2 | IPR033701 | |
| Domain | G8 | 2.44e-04 | 4 | 120 | 2 | PS51484 | |
| Domain | G8 | 2.44e-04 | 4 | 120 | 2 | SM01225 | |
| Domain | G8 | 2.44e-04 | 4 | 120 | 2 | PF10162 | |
| Domain | POLO_BOX | 2.44e-04 | 4 | 120 | 2 | PS50078 | |
| Domain | POLO_box_dom | 4.04e-04 | 5 | 120 | 2 | IPR000959 | |
| Domain | ITI_HC_C | 6.04e-04 | 6 | 120 | 2 | IPR010600 | |
| Domain | DUF3398 | 6.04e-04 | 6 | 120 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 6.04e-04 | 6 | 120 | 2 | IPR021816 | |
| Domain | ITI_HC_C | 6.04e-04 | 6 | 120 | 2 | PF06668 | |
| Domain | Pectin_lyase_fold/virulence | 1.12e-03 | 8 | 120 | 2 | IPR011050 | |
| Domain | VIT | 1.12e-03 | 8 | 120 | 2 | PF08487 | |
| Domain | VIT | 1.12e-03 | 8 | 120 | 2 | SM00609 | |
| Domain | EGF_CA | 1.15e-03 | 122 | 120 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.23e-03 | 124 | 120 | 5 | IPR001881 | |
| Domain | EGF_1 | 1.31e-03 | 255 | 120 | 7 | PS00022 | |
| Domain | PSI_integrin | 1.43e-03 | 9 | 120 | 2 | PF17205 | |
| Domain | Integin_beta_N | 1.43e-03 | 9 | 120 | 2 | IPR033760 | |
| Domain | EGF-like_CS | 1.49e-03 | 261 | 120 | 7 | IPR013032 | |
| Domain | EGF_2 | 1.63e-03 | 265 | 120 | 7 | PS01186 | |
| Domain | DAGK_acc | 1.78e-03 | 10 | 120 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 1.78e-03 | 10 | 120 | 2 | IPR000756 | |
| Domain | VIT | 1.78e-03 | 10 | 120 | 2 | PS51468 | |
| Domain | VIT | 1.78e-03 | 10 | 120 | 2 | IPR013694 | |
| Domain | DAGKa | 1.78e-03 | 10 | 120 | 2 | SM00045 | |
| Domain | VWFA | 1.93e-03 | 82 | 120 | 4 | PS50234 | |
| Domain | VWA | 2.10e-03 | 84 | 120 | 4 | SM00327 | |
| Domain | DHR-1_domain | 2.17e-03 | 11 | 120 | 2 | IPR027007 | |
| Domain | DHR_2 | 2.17e-03 | 11 | 120 | 2 | PS51651 | |
| Domain | DHR_1 | 2.17e-03 | 11 | 120 | 2 | PS51650 | |
| Domain | E2F_TDP | 2.17e-03 | 11 | 120 | 2 | PF02319 | |
| Domain | DHR-2 | 2.17e-03 | 11 | 120 | 2 | PF06920 | |
| Domain | DOCK | 2.17e-03 | 11 | 120 | 2 | IPR026791 | |
| Domain | DOCK_C | 2.17e-03 | 11 | 120 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 2.17e-03 | 11 | 120 | 2 | PF14429 | |
| Domain | DHR-2 | 2.17e-03 | 11 | 120 | 2 | IPR027357 | |
| Domain | E2F_TDP | 2.17e-03 | 11 | 120 | 2 | SM01372 | |
| Domain | E2F_WHTH_DNA-bd_dom | 2.17e-03 | 11 | 120 | 2 | IPR003316 | |
| Domain | ConA-like_dom | 2.93e-03 | 219 | 120 | 6 | IPR013320 | |
| Domain | Recoverin | 3.05e-03 | 13 | 120 | 2 | IPR028846 | |
| Domain | DAGKc | 3.54e-03 | 14 | 120 | 2 | SM00046 | |
| Domain | EFh | 3.55e-03 | 158 | 120 | 5 | SM00054 | |
| Domain | VWF_A | 3.82e-03 | 99 | 120 | 4 | IPR002035 | |
| Domain | Diacylglycerol_kinase_cat_dom | 4.07e-03 | 15 | 120 | 2 | IPR001206 | |
| Domain | DAGK | 4.07e-03 | 15 | 120 | 2 | PS50146 | |
| Domain | DAGK_cat | 4.07e-03 | 15 | 120 | 2 | PF00781 | |
| Domain | EGF_3 | 4.13e-03 | 235 | 120 | 6 | PS50026 | |
| Domain | Sushi | 4.55e-03 | 52 | 120 | 3 | PF00084 | |
| Domain | CCP | 5.05e-03 | 54 | 120 | 3 | SM00032 | |
| Domain | NAD/diacylglycerol_kinase | 5.23e-03 | 17 | 120 | 2 | IPR016064 | |
| Domain | EGF-like_dom | 5.46e-03 | 249 | 120 | 6 | IPR000742 | |
| Domain | EF_Hand_1_Ca_BS | 5.47e-03 | 175 | 120 | 5 | IPR018247 | |
| Domain | SUSHI | 5.60e-03 | 56 | 120 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 5.88e-03 | 57 | 120 | 3 | IPR000436 | |
| Domain | Channel_four-helix_dom | 5.88e-03 | 57 | 120 | 3 | IPR027359 | |
| Domain | - | 5.88e-03 | 57 | 120 | 3 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 6.28e-03 | 114 | 120 | 4 | IPR005821 | |
| Domain | Ion_trans | 6.28e-03 | 114 | 120 | 4 | PF00520 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 9425062 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30241936 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22828320 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 36395406 | ||
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 1.20e-05 | 2 | 121 | 2 | 24408017 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 36241903 | ||
| Pubmed | Glycosylation pattern of human inter-alpha-inhibitor heavy chains. | 1.20e-05 | 2 | 121 | 2 | 9677337 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 1384548 | ||
| Pubmed | Amino-terminal determinants of U-type inactivation of voltage-gated K+ channels. | 1.20e-05 | 2 | 121 | 2 | 12021261 | |
| Pubmed | Overexpression of a mammalian ethanolamine-specific kinase accelerates the CDP-ethanolamine pathway. | 1.20e-05 | 2 | 121 | 2 | 11044454 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26739753 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15353504 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24128992 | ||
| Pubmed | Selective expression of KCNA5 and KCNB1 genes in gastric and colorectal carcinoma. | 1.20e-05 | 2 | 121 | 2 | 33267786 | |
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 1.20e-05 | 2 | 121 | 2 | 27890662 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 7504674 | ||
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 1.20e-05 | 2 | 121 | 2 | 21439553 | |
| Pubmed | Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria. | 1.20e-05 | 2 | 121 | 2 | 15894573 | |
| Pubmed | Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. | 1.81e-05 | 15 | 121 | 3 | 23583980 | |
| Pubmed | 3.42e-05 | 257 | 121 | 7 | 16335952 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12906867 | ||
| Pubmed | Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages. | 3.59e-05 | 3 | 121 | 2 | 11039900 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 7513643 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10523297 | ||
| Pubmed | cDNA cloning of human inter-alpha-trypsin inhibitor discloses three different proteins. | 3.59e-05 | 3 | 121 | 2 | 3663330 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 2446322 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 7534067 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10921884 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 15282318 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12829703 | ||
| Pubmed | Reelin signaling pathway genotypes and Alzheimer disease in a Spanish population. | 3.59e-05 | 3 | 121 | 2 | 24384746 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 26728454 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 31484722 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 8576199 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 2476436 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 9000141 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 37196767 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 20463016 | ||
| Pubmed | Differential distribution of KChIPs mRNAs in adult mouse brain. | 7.17e-05 | 4 | 121 | 2 | 15363885 | |
| Pubmed | Genomic cloning and chromosomal assignment of the E2F dimerization partner TFDP gene family. | 7.17e-05 | 4 | 121 | 2 | 9027491 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 18393943 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 8755520 | ||
| Pubmed | Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase. | 7.17e-05 | 4 | 121 | 2 | 21939789 | |
| Pubmed | E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. | 7.17e-05 | 4 | 121 | 2 | 9704927 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 10100603 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 34080290 | ||
| Pubmed | Human plasma inter-alpha-trypsin inhibitor is encoded by four genes on three chromosomes. | 7.17e-05 | 4 | 121 | 2 | 2465147 | |
| Pubmed | Structure, alternative splicing, and expression of the human and mouse KCNIP gene family. | 7.17e-05 | 4 | 121 | 2 | 16112838 | |
| Pubmed | Modulation of A-type potassium channels by a family of calcium sensors. | 7.17e-05 | 4 | 121 | 2 | 10676964 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 18065659 | ||
| Pubmed | Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. | 7.17e-05 | 4 | 121 | 2 | 15894621 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 9.99e-05 | 211 | 121 | 6 | 24097068 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B RELN NPTX1 GALC AKAP17A CLASP1 DSP PPIG HNRNPA0 RBM5 CPNE1 HADHB DOCK6 | 1.05e-04 | 1082 | 121 | 13 | 38697112 |
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 19597481 | ||
| Pubmed | Phosphorylation of synucleins by members of the Polo-like kinase family. | 1.19e-04 | 5 | 121 | 2 | 19889641 | |
| Pubmed | GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation. | 1.19e-04 | 5 | 121 | 2 | 26571400 | |
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 16873769 | ||
| Pubmed | Eki2 is upregulated specifically in the testis during mouse sex determination. | 1.19e-04 | 5 | 121 | 2 | 15161093 | |
| Pubmed | Evidence showing an intermolecular interaction between KChIP proteins and Taiwan cobra cardiotoxins. | 1.19e-04 | 5 | 121 | 2 | 15184042 | |
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 1385302 | ||
| Pubmed | The genes for the inter-alpha-inhibitor family share a homologous organization in human and mouse. | 1.19e-04 | 5 | 121 | 2 | 1371941 | |
| Pubmed | 1.78e-04 | 6 | 121 | 2 | 15536069 | ||
| Pubmed | Association of polymorphisms of ABCA1 and ROS1 with hypertension in Japanese individuals. | 1.78e-04 | 6 | 121 | 2 | 18097620 | |
| Pubmed | 1.78e-04 | 6 | 121 | 2 | 23190452 | ||
| Pubmed | Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes. | 1.78e-04 | 6 | 121 | 2 | 20176812 | |
| Pubmed | 1.78e-04 | 6 | 121 | 2 | 24619415 | ||
| Pubmed | GWAS meta analysis identifies TSNARE1 as a novel Schizophrenia / Bipolar susceptibility locus. | 1.78e-04 | 6 | 121 | 2 | 24166486 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPM4 TMEM144 SLC9A8 TPCN2 MYO6 PORCN KCNIP3 ZNF248 DPP9 SEL1L3 RBM5 DIP2C CSMD1 DOCK6 TMEM63A | 2.12e-04 | 1489 | 121 | 15 | 28611215 |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 2.17e-04 | 84 | 121 | 4 | 15203218 | |
| Pubmed | 2.49e-04 | 7 | 121 | 2 | 15240882 | ||
| Pubmed | The physical association and phosphorylation of Cdc25C protein phosphatase by Prk. | 2.49e-04 | 7 | 121 | 2 | 10557092 | |
| Pubmed | Phosphorylation of Pkp1 by RIPK4 regulates epidermal differentiation and skin tumorigenesis. | 2.49e-04 | 7 | 121 | 2 | 28507225 | |
| Pubmed | 2.49e-04 | 7 | 121 | 2 | 7739537 | ||
| Pubmed | 2.49e-04 | 7 | 121 | 2 | 12588846 | ||
| Pubmed | 2.49e-04 | 7 | 121 | 2 | 31521773 | ||
| Pubmed | E2F-6, a member of the E2F family that can behave as a transcriptional repressor. | 2.49e-04 | 7 | 121 | 2 | 9501179 | |
| Pubmed | 2.49e-04 | 7 | 121 | 2 | 9852577 | ||
| Pubmed | 3.32e-04 | 8 | 121 | 2 | 22396660 | ||
| Pubmed | Proteomic analyses of native brain K(V)4.2 channel complexes. | 3.32e-04 | 8 | 121 | 2 | 19713751 | |
| Pubmed | 3.32e-04 | 8 | 121 | 2 | 16360038 | ||
| Pubmed | 3.43e-04 | 39 | 121 | 3 | 21347282 | ||
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 3.43e-04 | 39 | 121 | 3 | 19010793 | |
| Pubmed | 4.25e-04 | 9 | 121 | 2 | 9693030 | ||
| Pubmed | 4.25e-04 | 9 | 121 | 2 | 12482924 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 LZTR1 MAN2A2 DOCK9 ITGB4 SH2B2 POMGNT2 RPAP1 MEGF8 DIP2C DOCK6 PLK3 | 4.87e-04 | 1105 | 121 | 12 | 35748872 |
| Pubmed | Expression and localization of Inter-alpha Inhibitors in rodent brain. | 5.30e-04 | 10 | 121 | 2 | 26964679 | |
| Pubmed | Adiponectin and adiponectin receptors in the mouse preimplantation embryo and uterus. | 5.30e-04 | 10 | 121 | 2 | 21106494 | |
| Pubmed | Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1. | 5.30e-04 | 10 | 121 | 2 | 26075824 | |
| Pubmed | Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. | 5.30e-04 | 10 | 121 | 2 | 25173105 | |
| Pubmed | 5.30e-04 | 10 | 121 | 2 | 17302988 | ||
| Pubmed | Developmental expression of voltage-sensitive K+ channels in mouse skeletal muscle and C2C12 cells. | 5.30e-04 | 10 | 121 | 2 | 1383027 | |
| Pubmed | HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments. | 5.30e-04 | 10 | 121 | 2 | 18215327 | |
| Pubmed | 5.30e-04 | 10 | 121 | 2 | 18330979 | ||
| Pubmed | 5.30e-04 | 10 | 121 | 2 | 18314154 | ||
| Pubmed | 5.30e-04 | 10 | 121 | 2 | 37592023 | ||
| Pubmed | 5.75e-04 | 407 | 121 | 7 | 12693553 | ||
| Pubmed | 6.47e-04 | 11 | 121 | 2 | 17021016 | ||
| Pubmed | Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis. | 6.47e-04 | 11 | 121 | 2 | 21844209 | |
| Pubmed | 6.47e-04 | 11 | 121 | 2 | 12802069 | ||
| Pubmed | 6.47e-04 | 11 | 121 | 2 | 7504460 | ||
| Cytoband | 14q31 | 2.45e-04 | 9 | 121 | 2 | 14q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p11 | 3.69e-04 | 127 | 121 | 4 | chr10p11 | |
| GeneFamily | Transcription factor Dp family | 5.64e-05 | 3 | 79 | 2 | 987 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 8.29e-04 | 10 | 79 | 2 | 1178 | |
| GeneFamily | Potassium voltage-gated channel regulatory subunits|DASH family | 1.91e-03 | 15 | 79 | 2 | 858 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.98e-03 | 57 | 79 | 3 | 1179 | |
| GeneFamily | EF-hand domain containing | 2.71e-03 | 219 | 79 | 5 | 863 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.47e-08 | 199 | 121 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.51e-07 | 181 | 121 | 7 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.51e-07 | 181 | 121 | 7 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.71e-07 | 189 | 121 | 7 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.02e-07 | 190 | 121 | 7 | 8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-06 | 199 | 121 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-06 | 199 | 121 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.26e-06 | 126 | 121 | 6 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.68e-06 | 168 | 121 | 6 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.68e-06 | 168 | 121 | 6 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 6.91e-06 | 169 | 121 | 6 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-06 | 170 | 121 | 6 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-06 | 170 | 121 | 6 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-06 | 170 | 121 | 6 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-06 | 170 | 121 | 6 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-06 | 170 | 121 | 6 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 7.15e-06 | 170 | 121 | 6 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 183 | 121 | 6 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | (6)_Endothelial-F_(Lymphatics)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.12e-05 | 184 | 121 | 6 | 03ea613e00b45c81b752c14505a0538d698f551e | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.16e-05 | 185 | 121 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.16e-05 | 185 | 121 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.23e-05 | 187 | 121 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 187 | 121 | 6 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 189 | 121 | 6 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.31e-05 | 189 | 121 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.31e-05 | 189 | 121 | 6 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.35e-05 | 190 | 121 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.35e-05 | 190 | 121 | 6 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 192 | 121 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 192 | 121 | 6 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 192 | 121 | 6 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 194 | 121 | 6 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.51e-05 | 194 | 121 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-05 | 194 | 121 | 6 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-F_(Lymphatics)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.51e-05 | 194 | 121 | 6 | 9441202d6fa2ffbef9277d48ae9bc98876c26ec5 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.56e-05 | 195 | 121 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.56e-05 | 195 | 121 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | distal-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-05 | 195 | 121 | 6 | 8e0f67a67af3bc0b16f48a621f74540f136383b7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 195 | 121 | 6 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-05 | 196 | 121 | 6 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-05 | 196 | 121 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 1.70e-05 | 198 | 121 | 6 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | 05429f18e1d74880c1835568c86177f661b3477a | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | 306e28d31fd587409a12dcccc6b2abd7dc9c2e0a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 198 | 121 | 6 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.75e-05 | 199 | 121 | 6 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-05 | 199 | 121 | 6 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 121 | 6 | 1587d24b19f5bb64a3b6cc1df87c7c472cf41672 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 121 | 6 | a9c2041e54899cb8ccc026758647f3ae3ca457dd | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-05 | 199 | 121 | 6 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | be83f442179ba4217d12f0458059586ff3130991 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 126 | 121 | 5 | 54247ce9ee0a4f123f1fb225600a4ec698510a86 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-05 | 145 | 121 | 5 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.26e-05 | 148 | 121 | 5 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.84e-05 | 161 | 121 | 5 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-05 | 164 | 121 | 5 | a784f47f67a5eda84d58ad7d9400e3978edbb487 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-05 | 164 | 121 | 5 | 1a1795969673232191425dde84ab24ee6a98143f | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.56e-05 | 164 | 121 | 5 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-05 | 164 | 121 | 5 | 8f074940afdbda88a4b697a7ddc687e09a4b818b | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.56e-05 | 164 | 121 | 5 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.56e-05 | 164 | 121 | 5 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.56e-05 | 164 | 121 | 5 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.81e-05 | 165 | 121 | 5 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.81e-05 | 165 | 121 | 5 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.81e-05 | 165 | 121 | 5 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.32e-05 | 167 | 121 | 5 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 9.59e-05 | 168 | 121 | 5 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 169 | 121 | 5 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 169 | 121 | 5 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 171 | 121 | 5 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 171 | 121 | 5 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 171 | 121 | 5 | 355a27ea88410a84210f7e4298c7c4f90cf2f8a9 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 171 | 121 | 5 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 171 | 121 | 5 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-04 | 171 | 121 | 5 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 173 | 121 | 5 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-04 | 174 | 121 | 5 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.13e-04 | 174 | 121 | 5 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.13e-04 | 174 | 121 | 5 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.13e-04 | 174 | 121 | 5 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-04 | 174 | 121 | 5 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 175 | 121 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.19e-04 | 176 | 121 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.19e-04 | 176 | 121 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-04 | 177 | 121 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Erythrophagocytic_macrophages|Lung / Manually curated celltypes from each tissue | 1.26e-04 | 178 | 121 | 5 | b63cee443cc1b7416112bf610d7c9d41e4fa37ed | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.29e-04 | 179 | 121 | 5 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.29e-04 | 179 | 121 | 5 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-04 | 179 | 121 | 5 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 179 | 121 | 5 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.29e-04 | 179 | 121 | 5 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.08e-06 | 198 | 120 | 9 | 3219_UP | |
| Drug | nNOS inhibitor I | 7.24e-06 | 51 | 120 | 5 | CID000656911 | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 5627_UP | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 6000_UP | |
| Disease | arylamine N-acetyltransferase 1 measurement | 1.61e-05 | 2 | 119 | 2 | EFO_0801394 | |
| Disease | sodium channel subunit beta-2 measurement | 1.61e-05 | 2 | 119 | 2 | EFO_0803085 | |
| Disease | S-7-hydroxywarfarin measurement | 8.56e-05 | 110 | 119 | 5 | EFO_0803329 | |
| Disease | SUN domain-containing protein 3 measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0802102 | |
| Disease | single Ig IL-1-related receptor measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0802072 | |
| Disease | bipolar disorder, schizophrenia, schizoaffective disorder | 2.39e-04 | 6 | 119 | 2 | EFO_0005411, MONDO_0004985, MONDO_0005090 | |
| Disease | inter-alpha-trypsin inhibitor heavy chain H1 measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0801705 | |
| Disease | breast cancer (is_implicated_in) | 3.64e-04 | 150 | 119 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | coronary aneurysm | 3.81e-04 | 35 | 119 | 3 | EFO_1000881 | |
| Disease | high grade glioma (is_implicated_in) | 6.55e-04 | 42 | 119 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 8.55e-04 | 46 | 119 | 3 | EFO_0005325, HP_0012735 | |
| Disease | transient cerebral ischemia (is_implicated_in) | 8.66e-04 | 11 | 119 | 2 | DOID:224 (is_implicated_in) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.08e-03 | 111 | 119 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | illegal drug consumption | 1.22e-03 | 13 | 119 | 2 | EFO_0005431 | |
| Disease | Hamman-Rich syndrome | 1.42e-03 | 14 | 119 | 2 | C0085786 | |
| Disease | phoneme awareness | 1.42e-03 | 14 | 119 | 2 | EFO_0021812 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 1.64e-03 | 15 | 119 | 2 | EFO_0008223 | |
| Disease | cholesterol in medium HDL measurement | 1.76e-03 | 59 | 119 | 3 | EFO_0021903 | |
| Disease | neutrophil collagenase measurement | 1.87e-03 | 16 | 119 | 2 | EFO_0008248 | |
| Disease | bone mineral content measurement | 1.93e-03 | 130 | 119 | 4 | EFO_0007621 | |
| Disease | free cholesterol in HDL measurement | 1.94e-03 | 61 | 119 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 1.94e-03 | 61 | 119 | 3 | EFO_0022293 | |
| Disease | caudal anterior cingulate cortex volume measurement | 2.11e-03 | 17 | 119 | 2 | EFO_0010289 | |
| Disease | total lipids in HDL measurement | 2.13e-03 | 63 | 119 | 3 | EFO_0022307 | |
| Disease | anxiety | 2.14e-03 | 223 | 119 | 5 | EFO_0005230 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 2.34e-03 | 137 | 119 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | glycine measurement | 2.34e-03 | 137 | 119 | 4 | EFO_0009767 | |
| Disease | interstitial lung disease | 2.54e-03 | 67 | 119 | 3 | EFO_0004244 | |
| Disease | Usual Interstitial Pneumonia | 2.64e-03 | 19 | 119 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.64e-03 | 19 | 119 | 2 | C4721508 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.65e-03 | 68 | 119 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 2.92e-03 | 20 | 119 | 2 | C4721952 | |
| Disease | Idiopathic Pulmonary Fibrosis | 3.22e-03 | 21 | 119 | 2 | C1800706 | |
| Disease | phospholipids in large HDL measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022190 | |
| Disease | QRS duration, response to sulfonylurea | 3.86e-03 | 23 | 119 | 2 | EFO_0005055, EFO_0007922 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGSAHFAFTAEQYQQ | 576 | Q9H2F5 | |
| HEYFALQHADSSNFY | 46 | Q92556 | |
| FHSDFSNGGFFVLNF | 2236 | Q96PZ7 | |
| VVFGQFAFFHTALND | 1656 | Q7Z408 | |
| HANEAAFPFYRLFND | 361 | O00622 | |
| DHLQQGSANFIYDDF | 196 | P28676 | |
| DFLVDNETFSGFLYH | 146 | O95477 | |
| GNFNFGAYHTLEEIS | 116 | P48052 | |
| DAQSFDYDHDAFLGA | 41 | O43852 | |
| AFAEQIFYTGFIHSD | 346 | Q3MIX3 | |
| IHFNQELYGNFSAAS | 161 | O75493 | |
| NDLNYFFYFTHIDAG | 281 | Q9H7Y0 | |
| YRNHICNFFDFDTFG | 511 | Q8WUJ3 | |
| GFFEDASQYDENLSF | 206 | Q96GQ7 | |
| FEFHEAFSGQILANF | 376 | P55084 | |
| SANYNLFLVAAHEFG | 206 | P22894 | |
| IYKEFSFHNFNQAFG | 61 | Q9H0N5 | |
| FAHAFRNLTFEGYDG | 351 | P25092 | |
| SAYISNYAFANVFHG | 181 | Q8TD20 | |
| FDATQAFVGELAHFN | 366 | Q15818 | |
| AAAFVHFYGVSNLQE | 346 | Q96A54 | |
| LYGNGFEEVQSHAFN | 181 | P22888 | |
| ADGSFDYGLFQINSH | 66 | O75951 | |
| AFDRHLYVFGGAADN | 291 | Q8N653 | |
| GTLNSNAAYEQSHFF | 706 | Q5T3J3 | |
| YNLGFGHNVDFNFLE | 431 | P19827 | |
| FNGYFVHFFAPDNLD | 291 | P19823 | |
| FEHAYASQFGTFLGN | 426 | Q96QG7 | |
| NFDHTFGNASGFYIS | 381 | P98073 | |
| YQAFDIGNHFNEFAG | 276 | Q9NVF9 | |
| FYPHNFFDQFLATEV | 231 | P07098 | |
| FTVNVQGFFCHDSAY | 36 | Q32ZL2 | |
| FEGHSGTFYEFQELA | 3686 | Q9NYQ8 | |
| TFSLNFYGSDELHQF | 161 | Q8NGZ2 | |
| HLFSDANYNLLGFNA | 121 | Q7Z7M0 | |
| AFADLFADYATFAFH | 146 | P09848 | |
| FADYATFAFHSFGDL | 151 | P09848 | |
| DFFGFNHYTTVLAYN | 1676 | P09848 | |
| VFAALVEYAFAHFNA | 321 | O14764 | |
| YHSGFNQGFNFAEAV | 586 | Q9UGL1 | |
| EGFASFFEFLGVNHA | 416 | Q07075 | |
| YSNEAEEFIFFHGNT | 86 | Q8NAT1 | |
| INNHFFYESFGLYAV | 101 | Q9NVV4 | |
| DQGAFFVNYVIASAF | 551 | O94886 | |
| FSTESAFHYEADGAN | 261 | P16144 | |
| GFAFVEFYHLQDATS | 141 | P52756 | |
| GDASTYAHYLFNAFD | 96 | Q9NZI2 | |
| YKGFLFFHNQATSNE | 221 | Q6UWY5 | |
| IYFHGNEGSEFNFAT | 391 | P78509 | |
| YGGFFEDESFAVKHN | 91 | Q13427 | |
| ESAVSFHFSNYFVGF | 246 | Q9H237 | |
| FHFSNYFVGFLSEAT | 251 | Q9H237 | |
| SFFGYAVLEHFHDNT | 46 | Q13797 | |
| NALDAGLYDHFNATF | 291 | Q96A11 | |
| NEAIAGYSQYFHLAA | 431 | Q9H461 | |
| VHFSSDEFGNFDQTF | 2756 | Q4G0P3 | |
| AVYFAEADNQGTHFS | 451 | P22460 | |
| FNFEAGVHQYIDADT | 746 | Q14721 | |
| FYGAHFGDLDEQEFV | 1756 | Q96HP0 | |
| AFFGQAAQYQFTDSE | 1786 | Q9BZ29 | |
| NAESFQFHTEDYFGK | 2556 | P51587 | |
| VFNNYFSLGFDAHVT | 526 | O75912 | |
| SYDFHSESGLFLFQA | 141 | Q86TI2 | |
| HLKENAAYFQFFEEA | 371 | P15924 | |
| HFGATDLDVANFYVS | 91 | Q9H840 | |
| QAAAENVFFVAHSYG | 281 | Q8WUF8 | |
| FTIYGDESLQSDHFN | 1386 | Q9Y2E4 | |
| FFDSAYQGFASGNLE | 221 | P17174 | |
| IQFPYDQDTCFFAHF | 381 | Q5U5Z8 | |
| NQCQFFDYDTFGGHI | 506 | Q9UHN6 | |
| FRHVFGQAAKADQAY | 11 | Q6QEF8 | |
| FFSHFDGQDSYAAAV | 601 | Q9NYL2 | |
| HVQAQFGTLSDYFDA | 456 | P49641 | |
| DFSNEERFTGFDAHY | 121 | P48740 | |
| HLQFFSEFGNSDIYV | 276 | Q14449 | |
| VFNNYFSLGFDAHVT | 446 | Q13574 | |
| MFNFDAFYQAHYGEQ | 161 | Q96LL9 | |
| NYLAYDIGNHFNEFA | 336 | Q9HBU6 | |
| GGLNEDFSFHYAQLQ | 116 | P49770 | |
| HDQSFIENYAGIFHF | 151 | P20807 | |
| DATTYAHFLFNAFDA | 126 | Q9Y2W7 | |
| AHFLFNAFDADGNGA | 131 | Q9Y2W7 | |
| IGTHSFEFAQFDNFL | 666 | P54803 | |
| FAAQAAHQGTASQYF | 401 | Q99829 | |
| MAFYFDQDDAALEHF | 1 | P0C7X4 | |
| ASCDFAKGVFNAYHF | 256 | Q15743 | |
| GHQFEGAEEYASFLQ | 506 | P00748 | |
| ASANFHSLDDIYYFG | 486 | Q9BYC5 | |
| SFREDFHYNDTAGYF | 386 | Q68CR1 | |
| YNDAERFSDFHGYIQ | 481 | Q6UWF7 | |
| IHFQNSEFYGFSEFY | 421 | Q9Y227 | |
| FESGYSLHKGNFFQN | 136 | Q9Y2E8 | |
| LHQAKDFGNYLFNFA | 51 | Q96A49 | |
| NSAADFYFEGNIHQS | 71 | Q8N5J4 | |
| YADNFHADSIIGVAF | 321 | A4IF30 | |
| FEYLFNFDNTFEIHD | 296 | Q14188 | |
| HGFATLALAYYNFED | 181 | Q8N9L9 | |
| TFSFGGHLNFEAYVQ | 206 | Q02040 | |
| LLLAGAAEYDNFFQH | 351 | Q7Z460 | |
| FELIFSYLHFADNNE | 221 | Q6P3X8 | |
| HVNTQTDDDYAGFIF | 786 | P35443 | |
| LFSDGTVQVNFYGDH | 576 | Q9H4B4 | |
| FEYLFNFDNTFEIHD | 281 | Q14186 | |
| FTGYAQHDAQEFMAF | 581 | O94966 | |
| LASFNVGYADFFNEH | 581 | Q8N2C7 | |
| FNAGNIYFHHRQFSQ | 386 | Q86TZ1 | |
| RYFLDHFGNTANNFT | 76 | Q4G0A6 | |
| FGFVYFQNHDAADKA | 141 | Q13151 | |
| QYDLDYVFAHFSGIF | 226 | Q7Z5S9 | |
| EAFAFASHYNLDNLV | 166 | Q9H0I9 | |
| HEASELANYFQSSDF | 511 | Q8NCP5 | |
| FDLESAYNAFNRFLH | 206 | Q9UK41 | |
| NFFHGYFSIGDLNEA | 456 | Q8IZ13 | |
| IIGFAFEYFANSQFH | 31 | Q96LD8 | |
| FSRHFAANFLDVFGE | 61 | O14492 | |
| YANFLDHFEAVSFGD | 1211 | Q9BWH6 | |
| GKAFIDFYSFQNHET | 466 | Q9H7R0 | |
| QFIYNGFCSHGTSFE | 81 | A2RU30 | |
| FNDGTFQVNFYHDHT | 616 | Q9NYY3 | |
| YQSFGNNHFAERSFL | 91 | P19224 | |
| AGFVAYAFSQDSLTH | 211 | Q53S58 | |
| RGFAAAEFFHSNYDH | 636 | Q6BDS2 | |
| SFFAFEHSEEYQQAQ | 246 | Q9BQ70 | |
| DYNYSAFFLVDDGTH | 226 | Q8TD43 | |
| YSKNGQGFHDEAAFF | 216 | Q8NDW4 | |
| FLQSAQFLFGHYYFD | 421 | Q8NHX9 | |
| LGTSFAQNGFYHEAV | 311 | Q49AM3 | |
| DIAGFEYFEHNSFEQ | 456 | Q9UM54 |